发明名称 Nuclear Transport Modulators and Uses Thereof
摘要 The present invention relates to compounds of formula (I): and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising the compounds of formula (I) or their pharmaceutically acceptable salts, and methods of using said compounds, salts and compositions in the treatment of various disorders associated with CRM1 activity.;
申请公布号 US2016152596(A1) 申请公布日期 2016.06.02
申请号 US201414900469 申请日期 2014.06.20
申请人 KARYOPHARM THERAPEUTICS INC. 发明人 Baloglu Erkan;Shacham Sharon;McCauley Dilara;Kashyap Trinayan;Senapedis William;Landesman Yosef;Golan Gali;Kalid Ori;Shechter Sharon
分类号 C07D401/06;C07D249/08;C07D413/06;C07D405/06;C07D417/06;C07D403/06 主分类号 C07D401/06
代理机构 代理人
主权项 1. A compound of structural formula I: or a pharmaceutically acceptable salt thereof, wherein: X is —C(H)— or —N—; each R1 is independently selected from halo; haloalkyl; —(CH2)1-4R∘; —(CH2)0-4OR∘; —O—(CH2)0-4C(O)OR∘; —(CH2)0-4CH(OR∘)2; —(CH2)0-4SR∘; —(CH2)0-4-carbocyclyl, which may be substituted with R∘; —(CH2)0-4-aryl, which may be substituted with R∘; —(CH2)0-4-heterocyclyl, which may be substituted with R∘; —(CH2)0-4-heteroaryl, which may be substituted with R∘; —CH═CH-carbocyclyl, which may be substituted with R∘; —CH═CH-aryl, which may be substituted with R∘; —CH═CH-heterocyclyl, which may be substituted with R∘; —CH═CH-heteroaryl, which may be substituted with R∘; —NO2; —CN; —N3; —(CH2)0-4N(R∘)2; —(CH2)0-4N(R∘)C(O)R∘; —(CH2)0-4N(R∘)C(S)R∘; —(CH2)0-4N(R∘)C(O)NR∘2; —(CH2)0-4N(R∘)C(S)NR∘2; —(CH2)0-4N(R∘)C(O)OR∘; —(CH2)0-4N(R∘)N(R∘)C(O)R∘; —(CH2)0-4N(R∘)N(R∘)C(O)NR∘2; —(CH2)0-4N(R∘)N(R∘)C(O)OR∘; —(CH2)0-4C(O)R∘; —(CH2)0-4C(S)R∘; —(CH2)0-4C(O)OR∘; —(CH2)0-4C(O)SR∘; —(CH2)0-4OC(O)R∘; —(CH2)0-4OC(O)(CH2)0-4SR∘, —(CH2)0-4SC(S)SR∘; —(CH2)0-4SC(O)R∘; —(CH2)0-4C(O)NR∘2; —(CH2)0-4C(S)NR∘2; —(CH2)0-4C(S)SR∘; —(CH2)0-4OC(O)NR∘2; —(CH2)0-4C(O)N(OR∘)R∘; —(CH2)0-4C(O)C(O)R∘; —(CH2)0-4C(O)CH2C(O)R∘; —(CH2)0-4C(NOR∘)R∘; —(CH2)0-4SSR∘; —(CH2)0-4S(O)2R∘; —(CH2)0-4S(O)2OR∘; —(CH2)0-4OS(O)2R∘; —(CH2)0-4S(O)2NR∘2; —(CH2)0-4S(O)R∘; —(CH2)0-4N(R∘)S(O)2NR∘2; —(CH2)0-4N(R∘)S(O)2R∘; —(CH2)0-4N(OR∘)R∘; —(CH2)0-4C(NH)NR∘2; —(CH2)0-4P(O)2R∘; —(CH2)0-4P(O)R∘2; —(CH2)0-4OP(O)R∘2; —(CH2)0-4OP(O)(OR∘)2; —(CH2)0-4ON(R∘)2; and —(CH2)0-4C(O)O—N(R∘)2, wherein: each R∘ is independently hydrogen, C1-6 aliphatic, —CH2-carbocyclyl, —CH2-aryl, —CH2-heterocyclyl, —CH2-hetero aryl, —O(CH2)0-1-carbocyclyl, —O(CH2)0-1-aryl, —O(CH2)0-1-heterocyclyl, —O(CH2)0-1-heteroaryl, carbocyclyl, aryl, heterocyclyl or heteroaryl, or two independent occurrences of R∘, taken together with their intervening atom(s), form a 3-12-membered carbocyclyl, aryl, heterocyclyl or heteroaryl; andeach R∘ and each ring formed from two independent occurrences of R∘, taken together with their intervening atom(s), are optionally and independently substituted with one or more substituents selected from the group consisting of halo, CN, OH, unsubstituted C1-C3 alkyl, halo-C1-C3 alkyl, —NH2, —NO2, —NH(unsubstituted C1-C3 alkyl), —N(unsubstituted C1-C3 alkyl)2, —O—C1-C3 alkyl, —C(O)OH, —C(O)O-(unsubstituted C1-C3 alkyl), —C(O)-(unsubstituted C1-C3 alkyl), —O-(unsubstituted C1-C3 alkyl), and —S-(unsubstituted C1-C3 alkyl); R2 is selected from optionally substituted heteroaryl and optionally substituted aryl; one of Ra and Rb is hydrogen, and the other is selected from —C(O)—N(R5)(R6), —CN, —C(O)—O—R3, —C(S)—O—R3, —C(S)—N(R5)(R6), —C(O)—N(R7)—N(R5)(R6), —C(S)—N(R7)—N(R5)(R6), —C(O)—N(R7)—N(R7)—C(O)—R4, —C(S)—N(R7)—N(R7)—C(O)—R4, —C(O)—N(R7)—N(R7)—C(S)—R4, —C(S)—N(R7)—N(R7)—C(S)—R4, —C(O)—N(R7)—N(R7)—S(O)1-2—R4 and —C(S)—N(R7)—N(R7)—S(O)1-2—R4, wherein: R3 is selected from hydrogen, C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, carbocyclyl, aryl, heterocyclyl and heteroaryl;R4 is selected from —N(H)(C3-C6 cycloalkyl), —N(C1-C4 alkyl)(C3-C6 cycloalkyl), —C1-C6 alkyl, —(C0-C4 alkylene)-carbocyclyl, —(C0-C4 alkylene)-heterocyclyl, —(C0-C4 alkylene)-aryl, and —(C0-C4 alkylene)-heteroaryl;R5 and R6 are each independently selected from hydrogen, C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, carbocyclyl, aryl, heterocyclyl and heteroaryl; orR5 and R6 are taken together with the nitrogen atom to which they are commonly attached to form a heterocyclyl or heteroaryl;each R7 is independently hydrogen or C1-C4 alkyl; and n is 0, 1, 2, 3, 4 or 5; wherein: unless otherwise designated, each alkyl, alkenyl, alkynyl, alkylene, carbocyclyl, aryl, cycloalkyl, heterocyclyl and heteroaryl is optionally and independently substituted.
地址 Newton MA US